SCHEMBL13626663

SCHEMBL13626663

COCCN(C)CCOc1ccc(C(C)N(C)c2cc(OC)ccc2[C@@H]2CCc3cc(O)ccc3C2)cc1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.44
ESR2 Q92731 1/20 0.44
DRD2 P14416 9/20 0.35
DRD3 P35462 9/20 0.35
CYP26A1 O43174 1/20 0.34
DRD4 P21917 4/20 0.32
S1PR1 P21453 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
HTR1A P08908 1/20 0.31
SIGMAR1 Q99720 1/20 0.31
ADRB2 P07550 1/20 0.31
CYP2D6 P10635 1/20 0.31
CASP1 P29466 1/20 0.31
ROCK2 O75116 1/20 0.31
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
ACHE P22303 1/20 0.30
LMNA P02545 2/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13626661 0.92 ESR1 (0.47) ESR1ESR2DRD2DRD3CYP26A1
SCHEMBL13626643 0.89 ESR1 (0.44) ESR1ESR2DRD2DRD3CYP26A1
SCHEMBL13626640 0.88 ESR1 (0.46) ESR1ESR2DRD2DRD3CYP26A1
SCHEMBL13626639 0.88 ESR1 (0.47) ESR1ESR2DRD2DRD3CYP26A1
SCHEMBL13626662 0.87 ESR1 (0.42) ESR1ESR2DRD2DRD3
SCHEMBL13626637 0.87 ESR1 (0.45) ESR1ESR2DRD2DRD3CYP26A1
SCHEMBL13626642 0.87 ESR1 (0.45) ESR1ESR2DRD2DRD3CYP26A1
SCHEMBL228622 0.86 ESR1 (0.51) ESR1ESR2DRD2DRD3CYP26A1
SCHEMBL228480 0.86 ESR1 (0.51) ESR1ESR2DRD2DRD3CYP26A1
SCHEMBL229742 0.85 ESR1 (0.48) ESR1ESR2DRD2DRD3CYP26A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612114-B2 Such as (R)-6-{2-{ethyl[4-(2-ethylaminoethyl)benzyl]amino }-4-methoxyphenyl }-5,6,7,8-tetrahydronaphthalen-2-ol; osteoporosis; breast cancer EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-11-03 US disclosed